# DAPSONE
> **ANDA220103** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS LIFESCIENCES · Approved 2026-02-26
## Drug
- **FDA Application Number:** ANDA220103
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPSONE
- **Generic name:** DAPSONE
- **Active ingredients:** DAPSONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS LIFESCIENCES
- **Manufacturer:** Viona Pharmaceuticals Inc
- **First approval:** 2026-02-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220103)
---
*AI Analytics · CC0 1.0*